SNTI

SNTI

USD

Senti Biosciences Inc. Common Stock

$1.810-0.110 (-5.729%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.920

High

$2.020

Low

$1.800

Volume

0.05M

Company Fundamentals

Market Cap

47.3M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.19M

Exchange

NCM

Currency

USD

52-Week Range

Low $1.26Current $1.810High $16.94

Related News

GlobeNewswire

Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025

Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating relapsed/refractory Acute Myeloid

View more
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Senti Biosciences with a Buy rating and announces Price Target of $12.

View more
HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12